Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICStandard

PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA

RIBOFLAVIN 5'-PHOSPHATE SODIUM

Standard Dose
EQ 0.146% BASE/ML;EQ 0.146% BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA is listed in Drugs@FDA under application 203324 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient RIBOFLAVIN 5'-PHOSPHATE SODIUM Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.146% BASE/ML;EQ 0.146% BASE/ML Sponsor GLAUKOS Submission history Latest submission status date: 2025-02-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA is listed in Drugs@FDA under application 203324 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient RIBOFLAVIN 5'-PHOSPHATE SODIUM Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.146% BASE/ML;EQ 0.146% BASE/ML Sponsor GLAUKOS Submission history Latest submission status date: 2025-02-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA (RIBOFLAVIN 5'-PHOSPHATE SODIUM) | Drug Monograph | MedicHelpline